Health2 years ago
Optimus becomes the first company to conclude study of Molnupiravir Phase 3 Clinical Trial with promising results
The Day 5 and Day 10 of the treatment duration has given excellent results Mumbai, 2nd November 2021:Optimus Group has announced the successful completion of...
